Literature DB >> 22876144

Is breast cancer staging obsolete?

S A Narod.   

Abstract

Entities:  

Year:  2012        PMID： 22876144      PMCID： PMC3410827          DOI： 10.3747/co.19.1158

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  9 in total

Review 1.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare.

Authors:  Lee Cheng; Michael D Swartz; Hui Zhao; Asha S Kapadia; Dejian Lai; Paul J Rowan; Thomas A Buchholz; Sharon H Giordano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

Review 3.  Breast cancer in young women.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2012-06-26       Impact factor: 66.675

4.  Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening.

Authors:  Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2011-01-04       Impact factor: 4.872

5.  Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.

Authors:  Jennifer Y Wo; Kun Chen; Bridget A Neville; Nancy U Lin; Rinaa S Punglia
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

Review 6.  Tumor size and survival in breast cancer--a reappraisal.

Authors:  William D Foulkes; Jorge S Reis-Filho; Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2010-03-23       Impact factor: 66.675

7.  Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery.

Authors:  Tulin Cil; Eve Fishell; Wedad Hanna; Ping Sun; Ellen Rawlinson; Steven A Narod; David R McCready
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

8.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

9.  Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score.

Authors:  S Sahebjam; R Aloyz; D Pilavdzic; M-L Brisson; C Ferrario; N Bouganim; V Cohen; W H Miller; L C Panasci
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.